https://www.pharmalive.com/wp-content/uploads/2021/06/U.S.-signs-1.2-bln-deal-for-1.7-mln-courses-of-Mercks-experimental-COVID-19-drug-Reuters-6-9-21.jpg503960Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-03-08 10:42:392023-03-08 10:47:05Opko Health shares rise on Merck deal for experimental Epstein-Barr vaccine
